Literature DB >> 10805725

Class II phosphoinositide 3-kinases are downstream targets of activated polypeptide growth factor receptors.

A Arcaro1, M J Zvelebil, C Wallasch, A Ullrich, M D Waterfield, J Domin.   

Abstract

The class II phosphoinositide 3-kinases (PI3K) PI3K-C2alpha and PI3K-C2beta are two recently identified members of the large PI3K family. Both enzymes are characterized by the presence of a C2 domain at the carboxy terminus and, in vitro, preferentially utilize phosphatidylinositol and phosphatidylinositol 4-monophosphate as lipid substrates. Little is understood about how the catalytic activity of either enzyme is regulated in vivo. In this study, we demonstrate that PI3K-C2alpha and PI3K-C2beta represent two downstream targets of the activated epidermal growth factor (EGF) receptor in human carcinoma-derived A431 cells. Stimulation of quiescent cultures with EGF resulted in the rapid recruitment of both enzymes to a phosphotyrosine signaling complex that contained the EGF receptor and Erb-B2. Ligand addition also induced the appearance of a second, more slowly migrating band of PI3K-C2alpha and PI3K-C2beta immunoreactivity on sodium dodecyl sulfate-polyacrylamide gel electrophoresis. Since both PI3K enzymes can utilize Ca(2+) as an essential divalent cation in lipid kinase assays and since the catalytic activity of PI3K-C2alpha is refractory to the inhibitor wortmannin, these properties were used to confirm the recruitment of each PI3K isozyme to the activated EGF receptor complex. To examine this interaction in greater detail, PI3K-C2beta was chosen for further investigation. EGF and platelet-derived growth factor also stimulated the association of PI3K-C2beta with their respective receptors in other cells, including epithelial cells and fibroblasts. The use of EGF receptor mutants and phosphopeptides derived from the EGF receptor and Erb-B2 demonstrated that the interaction with recombinant PI3K-C2beta occurs through E(p)YL/I phosphotyrosine motifs. The N-terminal region of PI3K-C2beta was found to selectively interact with the EGF receptor in vitro, suggesting that it mediates the association of this PI3K with the receptor. However, the mechanism of this interaction remains unclear. We conclude that class II PI3K enzymes may contribute to the generation of 3' phosphoinositides following the activation of polypeptide growth factor receptors in vivo and thus mediate certain aspects of their biological activity.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10805725      PMCID: PMC85707          DOI: 10.1128/MCB.20.11.3817-3830.2000

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  66 in total

1.  Binding to the platelet-derived growth factor receptor transiently activates the p85alpha-p110alpha phosphoinositide 3-kinase complex in vivo.

Authors:  J Domin; R Dhand; M D Waterfield
Journal:  J Biol Chem       Date:  1996-08-30       Impact factor: 5.157

2.  The G beta gamma sensitivity of a PI3K is dependent upon a tightly associated adaptor, p101.

Authors:  L R Stephens; A Eguinoa; H Erdjument-Bromage; M Lui; F Cooke; J Coadwell; A S Smrcka; M Thelen; K Cadwallader; P Tempst; P T Hawkins
Journal:  Cell       Date:  1997-04-04       Impact factor: 41.582

3.  A family of phosphoinositide 3-kinases in Drosophila identifies a new mediator of signal transduction.

Authors:  L K MacDougall; J Domin; M D Waterfield
Journal:  Curr Biol       Date:  1995-12-01       Impact factor: 10.834

4.  Cloning and characterization of a novel class II phosphoinositide 3-kinase containing C2 domain.

Authors:  H Misawa; M Ohtsubo; N G Copeland; D J Gilbert; N A Jenkins; A Yoshimura
Journal:  Biochem Biophys Res Commun       Date:  1998-03-17       Impact factor: 3.575

5.  A novel class II phosphoinositide 3-kinase predominantly expressed in the liver and its enhanced expression during liver regeneration.

Authors:  F Ono; T Nakagawa; S Saito; Y Owada; H Sakagami; K Goto; M Suzuki; S Matsuno; H Kondo
Journal:  J Biol Chem       Date:  1998-03-27       Impact factor: 5.157

6.  Characterization of a 3-phosphoinositide-dependent protein kinase which phosphorylates and activates protein kinase Balpha.

Authors:  D R Alessi; S R James; C P Downes; A B Holmes; P R Gaffney; C B Reese; P Cohen
Journal:  Curr Biol       Date:  1997-04-01       Impact factor: 10.834

7.  Insulin activates the alpha isoform of class II phosphoinositide 3-kinase.

Authors:  R A Brown; J Domin; A Arcaro; M D Waterfield; P R Shepherd
Journal:  J Biol Chem       Date:  1999-05-21       Impact factor: 5.157

8.  Subsets of epidermal growth factor receptors during activation and endocytosis.

Authors:  D R Emlet; D K Moscatello; L B Ludlow; A J Wong
Journal:  J Biol Chem       Date:  1997-02-14       Impact factor: 5.157

9.  Cpk is a novel class of Drosophila PtdIns 3-kinase containing a C2 domain.

Authors:  L Molz; Y W Chen; M Hirano; L T Williams
Journal:  J Biol Chem       Date:  1996-06-07       Impact factor: 5.157

10.  Binding of a diphosphotyrosine-containing peptide that mimics activated platelet-derived growth factor receptor beta induces oligomerization of phosphatidylinositol 3-kinase.

Authors:  M J Layton; A G Harpur; G Panayotou; P I Bastiaens; M D Waterfield
Journal:  J Biol Chem       Date:  1998-12-11       Impact factor: 5.157

View more
  49 in total

1.  Hepatocyte growth factor activates phosphoinositide 3-kinase C2 beta in renal brush-border plasma membranes.

Authors:  Vladiana Crljen; Stefano Volinia; Hrvoje Banfic
Journal:  Biochem J       Date:  2002-08-01       Impact factor: 3.857

2.  Epidermal growth factor-induced tumor cell invasion and metastasis initiated by dephosphorylation and downregulation of focal adhesion kinase.

Authors:  Z Lu; G Jiang; P Blume-Jensen; T Hunter
Journal:  Mol Cell Biol       Date:  2001-06       Impact factor: 4.272

3.  Inhibition of class II phosphoinositide 3-kinase gamma expression by p185(Bcr-Abl) contributes to impaired chemotaxis and aberrant homing of leukemic cells.

Authors:  Weidong Yu; Xiaolin Sun; Hongxing Tang; Yunxia Tao; Zonghan Dai
Journal:  Leuk Lymphoma       Date:  2010-06

4.  Accelerated protein evolution analysis reveals genes and pathways associated with the evolution of mammalian longevity.

Authors:  Yang Li; João Pedro de Magalhães
Journal:  Age (Dordr)       Date:  2011-12-29

Review 5.  The emerging mechanisms of isoform-specific PI3K signalling.

Authors:  Bart Vanhaesebroeck; Julie Guillermet-Guibert; Mariona Graupera; Benoit Bilanges
Journal:  Nat Rev Mol Cell Biol       Date:  2010-04-09       Impact factor: 94.444

Review 6.  A role for the Ca(2+)-dependent tyrosine kinase Pyk2 in tonic depolarization-induced vascular smooth muscle contraction.

Authors:  Ryan D Mills; Mitsuo Mita; Michael P Walsh
Journal:  J Muscle Res Cell Motil       Date:  2015-07-07       Impact factor: 2.698

7.  Class II phosphoinositide 3-kinase alpha-isoform regulates Rho, myosin phosphatase and contraction in vascular smooth muscle.

Authors:  Yu Wang; Kazuaki Yoshioka; Mohammed Ali Azam; Noriko Takuwa; Sotaro Sakurada; Yuji Kayaba; Naotoshi Sugimoto; Isao Inoki; Takaharu Kimura; Tomoyuki Kuwaki; Yoh Takuwa
Journal:  Biochem J       Date:  2006-03-15       Impact factor: 3.857

8.  Phosphatidylinositol 3-kinase C2alpha is essential for ATP-dependent priming of neurosecretory granule exocytosis.

Authors:  Frédéric A Meunier; Shona L Osborne; Gerald R V Hammond; Frank T Cooke; Peter J Parker; Jan Domin; Giampietro Schiavo
Journal:  Mol Biol Cell       Date:  2005-07-29       Impact factor: 4.138

9.  Requirement for class II phosphoinositide 3-kinase C2alpha in maintenance of glomerular structure and function.

Authors:  David P Harris; Peter Vogel; Marie Wims; Karen Moberg; Juliane Humphries; Kanchan G Jhaver; Christopher M DaCosta; Melanie K Shadoan; Nianhua Xu; Gwenn M Hansen; Sanjeevi Balakrishnan; Jan Domin; David R Powell; Tamas Oravecz
Journal:  Mol Cell Biol       Date:  2010-10-25       Impact factor: 4.272

10.  Vascular endothelial growth factor acts through novel, pregnancy-enhanced receptor signalling pathways to stimulate endothelial nitric oxide synthase activity in uterine artery endothelial cells.

Authors:  Mary A Grummer; Jeremy A Sullivan; Ronald R Magness; Ian M Bird
Journal:  Biochem J       Date:  2009-01-15       Impact factor: 3.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.